ATE540104T1 - Suspensionskultur von mykobakterien - Google Patents

Suspensionskultur von mykobakterien

Info

Publication number
ATE540104T1
ATE540104T1 AT02782795T AT02782795T ATE540104T1 AT E540104 T1 ATE540104 T1 AT E540104T1 AT 02782795 T AT02782795 T AT 02782795T AT 02782795 T AT02782795 T AT 02782795T AT E540104 T1 ATE540104 T1 AT E540104T1
Authority
AT
Austria
Prior art keywords
mycobacteria
standardized
antifoam agent
suspension culture
culture
Prior art date
Application number
AT02782795T
Other languages
English (en)
Inventor
Guido Dietrich
Erika Hundt
Heinz Weber
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of ATE540104T1 publication Critical patent/ATE540104T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT02782795T 2001-09-27 2002-09-25 Suspensionskultur von mykobakterien ATE540104T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01123146 2001-09-27
PCT/EP2002/010772 WO2003029478A2 (en) 2001-09-27 2002-09-25 Cultivation of dispersed mycobacteria

Publications (1)

Publication Number Publication Date
ATE540104T1 true ATE540104T1 (de) 2012-01-15

Family

ID=8178750

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02782795T ATE540104T1 (de) 2001-09-27 2002-09-25 Suspensionskultur von mykobakterien

Country Status (5)

Country Link
US (1) US20130059364A1 (de)
AT (1) ATE540104T1 (de)
AU (1) AU2002347030A1 (de)
DK (1) DK1430109T3 (de)
WO (1) WO2003029478A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070072293A1 (en) * 2005-09-26 2007-03-29 Manoj Kole Process for stabilization of bacterial cells
EP2696891B1 (de) * 2011-04-11 2019-06-26 Alarum Development Ltd Neue impfstoffe zur vorbeugung und behandlung von tuberkulose
CN102925400B (zh) * 2012-04-17 2014-01-29 韩瑞发 重组人干扰素-α-2b-BCG的生产方法
KR101716239B1 (ko) * 2015-02-12 2017-03-28 사단법인대한결핵협회 마이코박테리아의 성장 증진용 조성물 및 방법
CN113122484B (zh) * 2021-06-03 2023-11-03 郑州安图生物工程股份有限公司 一种非结核分枝杆菌的冻干保护剂及其制备方法和保藏方法
CN113308431B (zh) * 2021-06-15 2022-09-16 广西大学 一种番茄灰霉病菌分生孢子的移植与分散方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US4358538A (en) * 1978-08-07 1982-11-09 The Upjohn Company Mycobacterium fortuitum mutant
JPS5571489A (en) * 1978-11-21 1980-05-29 Mitsui Toatsu Chem Inc Culture in liquid of tubercle bacilli
US5091308A (en) * 1990-01-29 1992-02-25 The Board Of Trustees Of The University Of Illinois Process for the enzymatic dispersal of mycobacterium bovis - bcg

Also Published As

Publication number Publication date
DK1430109T3 (da) 2012-04-02
US20130059364A1 (en) 2013-03-07
AU2002347030A1 (en) 2003-04-14
WO2003029478A3 (en) 2004-01-29
WO2003029478A2 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
IT1319655B1 (it) Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
YU40701A (sh) Piperidini kao modulatori ccr5
WO2004001007A3 (en) Buffered formulations for concentrating antibodies and methods of use thereof
CY1113241T1 (el) Μεθοδος για την παραγωγη ενεργου συστατικου ενος φαρμακευτικου ή διαγνωστικου μεσου εντος καλλιεργειας αιωρηματος κυτταρων mdck
NO923469L (no) Chymotrypsin-lignende proteaser og deres inhibitorer
CY1110716T1 (el) Πολλαπλασιασμος ιων εντος κυτταροκαλλιεργειας
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
DE69732407D1 (de) Verfahren fuer die replikation von influenza in zellkultur und die bei diesem verfahren hergestellten influenza-viren
EA200400026A1 (ru) Ингибиторы вич-протеазы, содержащие их композиции, их фармацевтические применения и вещества для их синтеза
EA200601187A1 (ru) Стволовые клетки
DE60037450D1 (de) Funf-helix protein
DE69634045D1 (de) Antithrombotische diamine
EA200401111A1 (ru) Биполярные соли транс-каротиноидов и их применение
ES2110414T3 (es) Derivados de sacarina utiles como inhibidores de enzimas proteoliticas y su preparacion.
Vyas et al. Identification of peptidases in highly pathogenic vs. weakly pathogenic Naegleria fowleri amebae
DE60319083D1 (de) Pharmazeutische verbindung und methoden zur behandlung von menschlichen karzinomen mittels arginin entzug
ATE540104T1 (de) Suspensionskultur von mykobakterien
AR039186A1 (es) Celulas madre indiferenciadas programables de origen monocitaro, su obtencion y uso
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht
BR0212467A (pt) Procedimento de preparação dos ácidos hidróxigraxos insaturados e de seus ésteres, sua utilização em preparações farmacêuticas e/ou cosméticas
UA81649C2 (ru) Эфиры карбаминовой кислоты, которые имеют антихолинергическое действие
DE60324948D1 (de) Herstellungsverfahren für iturin a und dessen homologe
UA107177C2 (uk) Імуногенна композиція цвс2 та спосіб приготування такої композиції
ATE335745T1 (de) Verfahren zur herstellung von protease hemmenden zwischenprodukten
DK1406927T3 (da) Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose